Tharimmune Announces Expanded Role as Super Validator on Canton Network
Tharimmune (NASDAQ: THAR) was approved on Jan 26, 2026 to operate a Super Validator on the Canton Network, allowing it to help secure transactions and accrue Canton Coin (CC) rewards to bolster its digital asset treasury.
Rhea-AI Summary
Tharimmune (NASDAQ: THAR) was approved on Jan 26, 2026 to operate a Super Validator on the Canton Network, allowing it to help secure transactions and accrue Canton Coin (CC) rewards to bolster its digital asset treasury. Tharimmune will publish quarterly research on onchain analytics, governance, tokenomics and roadmap updates, and will host quarterly public webinars to engage ecosystem participants. The announcement notes Super Validators support >700,000 daily transactions and $9 trillion in monthly transaction volume on the Canton Network. Tharimmune established its digital asset treasury strategy in November 2025 and plans to acquire CC and invest in Canton-based applications to drive institutional adoption. Tharimmune is identified as the first publicly traded company supported by the Canton Foundation.
Positive
- Approved to operate as a Super Validator on Canton Network
- Ability to accrue CC rewards to bolster digital asset treasury
- Commits to quarterly research and public webinars to drive ecosystem engagement
- Plans to invest in Canton-based applications to accelerate institutional adoption
Negative
- Concentration of digital treasury strategy focused on Canton Coin (CC)
- Operational role and value tied to Canton Network performance and adoption
Details
News Market Reaction – THAR
In the Jan 26 session, THAR gained 9.12%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Daily transactions
- 700,000
- Canton Network daily transaction count cited by Tharimmune
- Monthly transaction volume
- $9 trillion
- Canton Network monthly transaction volume referenced in the release
- Strategy start date
- November 2025
- Establishment of Tharimmune’s digital asset treasury strategy
Historical Context
-
Closed $55M underwritten registered direct offering to fund Canton strategy.
-
Priced $55M underwritten registered offering of shares and pre-funded warrants.
-
Highlighted DTCC’s U.S. Treasuries tokenization and Canton Network scale metrics.
-
Named new CFO to lead and expand Canton Coin treasury infrastructure.
-
Received positive FDA feedback on TH104 prophylaxis program and modeling plan.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
super validator technical
onchain technical
tokenomics technical
atomic settlement technical
programmable privacy technical
digital asset treasury strategy financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Advances Digital Asset Treasury Strategy Through Contributions to Canton Network
Tharimmune will provide in-depth quarterly research highlighting onchain analytics, community development news, governance and "tokenomics" updates, as well as roadmap updates for the network. Additionally, Tharimmune will host publicly available webinars each quarter, driving dialogue among ecosystem participants.
"Super Validators play a critical role on the Canton Network, responsible for over 700,000 daily transactions totaling
"Tharimmune has demonstrated a unique ability to mobilize and drive alignment with institutional capital as we shape the future of our onchain financial system. We are happy to welcome Tharimmune as a Super Validator on the Canton Network," said Melvis Langyintuo, Executive Director at the Canton Foundation.
The Canton Network is increasingly being chosen by global financial institutions for its ability to deliver programmable privacy at a time when firms continue to move transactions onchain in record numbers. Configurable privacy on the Canton Network allows market participants to capitalize on instantaneous settlement while maintaining discretion of critical information shared only with authorized counterparties and regulators.
Tharimmune established its differentiated digital asset treasury strategy in November 2025. In addition to driving value through CC acquisition and operating as a Super Validator, Tharimmune intends to invest in applications built on the Canton Network that accelerate institutional utility and adoption across capital markets. Tharimmune is the first and only publicly traded company supported by the Canton Foundation.
About Tharimmune
Tharimmune, Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network, Tharimmune also operates clinical-stage biotech research and development. For more information, visit: www.tharimmune.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements" within the meaning of
Contacts
Media:
Gasthalter & Co.
(212) 257-4170
canton@gasthalter.com
Investors:
ir@tharimmune.com
X: @TharimmuneInc
LinkedIn: https://www.linkedin.com/company/tharimmune-inc/
Website: https://tharimmune.com/
View original content:https://www.prnewswire.com/news-releases/tharimmune-announces-expanded-role-as-super-validator-on-canton-network-302670020.html
SOURCE Tharimmune, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.